Study of Safety and Immunogenicity of BVRS-GamVac-Combi

Clinical trial NCT04128059 · UNKNOWN

Trial details

NCT number: NCT04128059
Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

MERS (Middle East Respiratory Syndrome)MERS

Start date: 2019-11-06
Primary completion: 2021-07-01
Enrollment: 268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.